Behavior-change interventions to improve antimicrobial stewardship in human health, animal health, and livestock agriculture: A systematic review

Antimicrobial resistance (AMR) is an economic, food security, and global health threat that is driven by a multitude of factors including the overuse and misuse of antimicrobials in the human health, animal health, and agriculture sectors. Given the rapid emergence and spread of AMR and the relative lack of development of new antimicrobials or alternative therapies, there is a need to develop and implement non-pharmaceutical AMR mitigation policies and interventions that improve antimicrobial stewardship (AMS) practices across all sectors where antimicrobials are used. We conducted a systematic literature review per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to identify peer-reviewed studies that described behavior-change interventions that aimed to improve AMS and/or reduce inappropriate antimicrobial use in the human health, animal health, and livestock agriculture stakeholders. We identified 301 total publications - 11 in the animal health sector and 290 in the human health sector - and assessed these interventions using metrics across five thematic areas- (1) antimicrobial use (AMU), (2) adherence to clinical guidelines, (3) AMS, (4) AMR, and (5) clinical outcomes. The lack of studies in the animal health sector precluded a meta-analysis. Among studies in the human health sector, 35.7% reported significant (p<0.05) pre- to post-intervention decreases in AMU, 73.7% reported significant improvements in adherence of antimicrobial therapies to clinical guidelines, 45% demonstrated significant improvements in AMS practices, 45.5% reported significant decreases in the proportion of isolates that were resistant to antibiotics or the proportion of patients with drug-resistant infections across 17 antimicrobial-organism combinations, and few studies reported statistically significant changes in clinical outcomes. We did not identify any overarching intervention type nor characteristics associated with successful improvement in AMS, AMR, AMU, adherence, nor clinical outcomes.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 5, 2023.
Introduction antimicrobials in the human health, animal health, and agriculture sectors. Although antimicrobial use

48
(AMU) and consumption (AMC) surveillance is limited in the human and animal health sectors, available 49 evidence demonstrates that AMU is increasing globally. Analysis of AMC rates, approximated from data 50 on national-level antimicrobial sales data, indicated a 39% increase in per capita AMC in the human 51 health sector between 2000 and 2015, rising from 11.3 to 15.7 daily defined doses per 1,000 people per 52 day (DIDs) (8). Concerningly, the use of World Health Organization-designated "Watch" antibiotics has 53 increased faster than "Access" antibiotics. Between 2000 and 2015, there was a 90.9% increase in the 54 global per capita consumption of "Watch" antibiotics, from 3.3 to 6.3, compared to a 26.2% increase in 55 the global per capita consumption "Access" antibiotics which rose from 8.4 to 10.6 DIDs in the same 56 period (9). Previous studies show clinically inappropriate AMU rates as high as 55% in South Africa, 57 88% in Pakistan, and 61% in China in the human health sector; however, emerging evidence suggests 58 there is significant heterogeneity in AMU practices across countries and clinical settings (10-13). Best . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 5, 2023. ; https://doi.org/10.1101/2023.01.04.23284191 doi: medRxiv preprint randomized controlled trials and observational studies (including pre/post study designs) were 111 included. Review articles were screened for additional relevant studies. (4)

Results
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 5, 2023. ; https://doi.org/10.1101/2023.01.04.23284191 doi: medRxiv preprint were determined to be irrelevant based on the title and abstract review; and 36 were identified as review 162 articles. Following full-text review, a total of 301 publications -11 in the animal health sector and 290 in 163 the human health sector (S1 and S2 files) -met the study's inclusion criteria and underwent data 164 extraction (Fig 1)

173
Animal health and agriculture sectors 174 Only 11 studies conducted in the animal health or agriculture sector met our study's inclusion 175 criteria, and given heterogeneity across the study types, outcomes, and types of statistics reported, a meta-176 analysis was not possible. Seven of the studies (63.6%) assessed the impact of interventions among food-177 producing animals including swine (n=3), poultry (n=1), dairy cows (n=2), and calves (n=1)  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 5, 2023. ; https://doi.org/10.1101/2023.01.04.23284191 doi: medRxiv preprint review and feedback of AMU; and programs to implement infection prevention and control measures.

186
Overall AMU decreased significantly (p value < 0.05) for all but one study which implemented an online 187 stewardship tool among calf farmers in Switzerland (29). Three studies assessed pre-to post-intervention 188 changes in animal health status and productivity and documented either no change or an improvement in 189 mortality, animal weight gain, or feed conversion ratio associated with the intervention (28,32,33). One

206
Given the smaller number of studies that utilized RCTs designs and the heterogeneity across data 207 and outcomes, a meta-analysis of RCTs was not possible; therefore, we focus our meta-analysis on 208 interventions evaluated through pre/post observational study designs.

209
Theme 1: Antimicrobial use . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

210
Of 290 studies that described interventions in the human healthcare setting and met our eligibility 211 criteria, we extracted AMU data, quantified as a proportion of patients who received an antimicrobial 212 before and after the study intervention, from 42 studies (Fig 2).  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 5, 2023. ; https://doi.org/10.1101/2023.01.04.23284191 doi: medRxiv preprint 12 260 recommendations of discharge prescriptions (40). This study documented a significant pre-to post-261 intervention decrease in fluoroquinolone use (38.1 to 25%, p=0.001) and a significant increase in the 262 proportion of patients prescribed azithromycin (12 to 20%, p=0.01). Across all datapoints reported in 263 these 7 studies, there was an average 1.8% decrease in the proportion of patients receiving antimicrobials.

264
Theme 2: Appropriateness of therapy and adherence to treatment guidelines, 265 protocols, and policies 266 We extracted data from 38 studies that described pre-to post-intervention changes in the 267 adherence/concordance of AMU or prescribing practices with local, national, or international treatment 268 guidelines or protocols (Fig 3). Of those, 28 studies (73.7%) reported a significant improvement in 269 appropriateness and/or adherence while 1 study (2.6%) reported a significant decline. Most studies that is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 5, 2023.

290
Theme 3: Antimicrobial stewardship 291 We extracted AMS data from 20 studies; 9 (45%) of which demonstrated significant 292 improvements in AMS practices and 1 (5%) that reported a significant reduction in AMS practices (Fig   293  4). Two of three studies (66.7%) that assessed changes in intravenous to oral stepdown reported pre-to intervention on prescribers at a pediatric hospital in Iran obtaining blood cultures to aid in diagnosis and 306 found that the proportion of patients whose care included a blood culture for diagnosis declined from 307 23.9% pre-intervention to 4.4% post-intervention (OR: 0.1, 95% CI: 0.04-0.5; Chi square p<0.001). The 308 study also reported non-significant pre-to post-intervention declines in the proportion of patients whose 309 diagnosis was aided by tracheal and urine cultures.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 5, 2023. ; https://doi. org/10.1101org/10. /2023  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 5, 2023. ; https://doi.org/10.1101/2023.01.04.23284191 doi: medRxiv preprint The 3 studies that reported a combination of significant pre-to post-intervention changes were 336 conducted in nursing homes or tertiary/teaching hospitals (n=2); two of these interventions consisted of 337 bundled AMS activities. One intervention described by Ziv-On et al. consisted of review and feedback, 338 education, and restricted use of certain antibiotics that required pre-prescription authorization (41). There second-generation cephalosporins (cefuroxime) from 11.3 (SD: 0.7) to 8.6 (SD: 2.7), and amoxicillin-347 clavulanic acid from 19.8 (SD: 4.7) to 9.9 (SD: 3.7).

348
The second bundled study by Tandan  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

365
Theme 5: Clinical Outcomes 366 We extracted clinical outcome data from 57 of 301 total studies (Fig 6). Of three studies that
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 5, 2023. ; https://doi.org/10.1101/2023.01.04.23284191 doi: medRxiv preprint significant (p<0.05) associations between pre-to post-intervention absolute differences and intervention 387 type, duration, or setting of intervention across any of our study outcomes in Themes 1-5.

407
AMU, and AMS and may have also introduced a publication bias where successful studies are more 408 likely to be more published than unsuccessful interventions. Moreover, we only considered interventions 409 that targeted behavior change among stakeholder groups involved in the use or prescription of . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 5, 2023. ; https://doi.org/10.1101/2023.01.04.23284191 doi: medRxiv preprint https://access.clarivate.com/login?app=wos&alternative=true&shibShireURL=https:%2F%2Fww . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 5, 2023. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 5, 2023. ; https://doi.org/10.1101/2023.01.04.23284191 doi: medRxiv preprint